Latest News and Press Releases
Want to stay updated on the latest news?
-
NEW YORK, Nov. 27, 2017 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against RYB Education, Inc. (“RYB” or the “Company”) (NYSE:RYB) and certain of its...
-
NEW YORK, Nov. 24, 2017 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Novan, Inc. (“Novan” or the “Company”) (NASDAQ:NOVN) and certain of its...
-
NEW YORK, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Alkermes plc (“Alkermes” or the “Company”) (NASDAQ:ALKS) and certain of its...
-
NEW YORK, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Ubiquiti Networks, Inc. (“Ubiquiti” or the “Company”) (NASDAQ:UBNT) and certain...
-
NEW YORK, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Frontier Communications Corporation (“Frontier” or the “Company”) (NASDAQ:FTR)...
-
NEW YORK, Nov. 19, 2017 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Omega Healthcare Investors, Inc. (“Omega” or the “Company”) (NYSE:OHI) and...
-
NEW YORK, Nov. 18, 2017 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Intercept Pharmaceuticals, Inc. (“Intercept” or the “Company”) (NASDAQ:ICPT)...
-
NEW YORK, Nov. 17, 2017 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Acorda Therapeutics, Inc. (“Acorda” or the “Company”) (NASDAQ:ACOR) and certain...
-
NEW YORK, Nov. 16, 2017 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Trivago N.V., Inc. (“Trivago” or the “Company”) (NASDAQ:TRVG) and certain of...
-
NEW YORK, Nov. 16, 2017 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Ford Motor Company (“Ford” or the “Company”) (NYSE:F) and certain of its...